Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Indirect mesentericoportography with prostaglandin E1].

J Lammer, F Beaufort, H Steiner

    Wiener Klinische Wochenschrift
    |September 13, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Sensations in Drowning.

    Hall's journal of health·2022
    Same author

    [Disabled elderly people waiting for institutionalization to a hospital ward: prospective study in the administrative district of Strasbourg (France)].

    Revue d'epidemiologie et de sante publique·2008
    Same author

    Motor-skill learning in a novel running-wheel task is dependent on D1 dopamine receptors in the striatum.

    Neuroscience·2008
    Same author

    Olanzapine plasma concentration in a newborn.

    Journal of psychopharmacology (Oxford, England)·2008
    Same author

    The impact of risk factors and more stringent diagnostic criteria of gestational diabetes on outcomes in central European women.

    The Journal of clinical endocrinology and metabolism·2008
    Same author

    Ex-Utero Intrapartum Treatment (EXIT) in a giant case of Congenital Cystic Adenomatoid Malformation (CCAM) of the lung.

    Ultraschall in der Medizin (Stuttgart, Germany : 1980)·2007

    Prostaglandin E1 did not improve contrast enhancement in indirect mesentericoportography compared to tolazoline. However, prostaglandin E1 showed fewer side effects, suggesting a potential safety advantage in vascular imaging procedures.

    Area of Science:

    • Vascular imaging
    • Interventional radiology
    • Pharmacology

    Background:

    • Indirect mesentericoportography is a key diagnostic tool.
    • Vasodilators are used to improve contrast enhancement.
    • Comparing different vasodilators is crucial for optimizing procedures.

    Purpose of the Study:

    • To compare the efficacy of prostaglandin E1 with tolazoline in enhancing contrast in indirect mesentericoportography.
    • To evaluate the side effect profiles of prostaglandin E1 and tolazoline in this context.

    Main Methods:

    • Indirect mesentericoportography was performed in 36 patients receiving prostaglandin E1.
    • A control group of 20 patients received tolazoline.
    • Contrast enhancement of the superior mesenteric vein was assessed and compared.

    Related Experiment Videos

    Main Results:

    • No significant difference in contrast enhancement of the superior mesenteric vein was observed between prostaglandin E1 and tolazoline.
    • Prostaglandin E1 was associated with fewer reported side effects than tolazoline.

    Conclusions:

    • Prostaglandin E1 does not offer superior contrast enhancement compared to tolazoline in indirect mesentericoportography.
    • Prostaglandin E1 may be a safer alternative due to a reduced side effect profile.